End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.07 NZD | -1.92% | +0.33% | -12.29% |
Sales 2024 * | 193M 115M | Sales 2025 * | 220M 131M | Capitalization | 322M 192M |
---|---|---|---|---|---|
Net income 2024 * | 15M 8.95M | Net income 2025 * | 17M 10.14M | EV / Sales 2024 * | 1.82 x |
Net Debt 2024 * | 28.28M 16.87M | Net Debt 2025 * | 26.88M 16.03M | EV / Sales 2025 * | 1.58 x |
P/E ratio 2024 * |
21.2
x | P/E ratio 2025 * |
18.6
x | Employees | 100 |
Yield 2024 * |
0.53% | Yield 2025 * |
0.74% | Free-Float | 25.53% |
Latest transcript on AFT Pharmaceuticals Limited
1 day | -1.92% | ||
1 week | +0.33% | ||
Current month | -1.92% | ||
1 month | +1.32% | ||
3 months | -13.76% | ||
6 months | -9.71% | ||
Current year | -12.29% |
Managers | Title | Age | Since |
---|---|---|---|
Marree Atkinson
FOU | Founder | - | 97-09-03 |
Hartley Atkinson
FOU | Founder | - | 97-09-03 |
Malcolm Tubby
DFI | Director of Finance/CFO | - | 97-09-03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Theodore Witek
BRD | Director/Board Member | 67 | 20-12-22 |
David Flacks
CHM | Chairman | - | 15-06-21 |
Hartley Atkinson
FOU | Founder | - | 97-09-03 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 3.07 | -1.92% | 23,824 |
24-04-23 | 3.13 | +1.29% | 1,862 |
24-04-22 | 3.09 | -1.59% | 373 |
24-04-19 | 3.14 | +2.61% | 2,579 |
24-04-18 | 3.06 | 0.00% | 4,051 |
End-of-day quote New Zealand S.E., April 23, 2024
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.29% | 191M | |
+24.74% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+13.45% | 233B | |
+5.63% | 201B | |
-10.22% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |
- Stock Market
- Equities
- AFT Stock